BiotechTubeBiotechTube
Home/Asieris Pharmaceuticals/Ms. Joanna Zhang
MJ

Ms. Joanna Zhang

Chief Medical Officer

Asieris Pharmaceuticals

Therapeutic Areas

Urologic OncologyWomen's HealthBreast and Gynecologic OncologyAutoimmune DiseasesInfectious Diseases

Asieris Pharmaceuticals Pipeline

DrugIndicationPhase
Vesique® (APL-1202)Non-Muscle Invasive Bladder Cancer (NMIBC)Phase 3
Cevira® (APL-1702)Cervical Precancerous Lesions (HSIL/CIN 2/3)Approved
APL-2401 (ASN-8639)FGFR2/3-Driven Advanced Solid TumorsPhase 1
APL-1501Urological TumorsNot Specified
APL-1401Moderately to Severely Active Ulcerative ColitisNot Specified
APL-2301Acinetobacter baumannii InfectionNot Specified
APL-2302Ovarian Cancer, Breast CancerNot Specified
AT-014Urological TumorsNot Specified

Leadership Team at Asieris Pharmaceuticals

DN
Dr. Ningshu Liu
Chief Scientific Officer
View full Asieris Pharmaceuticals profile